Literature DB >> 11152372

Involvement of Ca2+ -activated K+ channels in ginsenosides-induced aortic relaxation in rats.

Z Li1, X Chen, Y Niwa, S Sakamoto, Y Nakaya.   

Abstract

Ginsenosides (GS), an extract of Panax ginseng, have been reported to be effective in inducing vascular relaxation mediated by nitric oxide (NO) release. The present experiments were designed to determine whether this GS-induced vasorelaxation also involves Ca2+ -activated K+ (KCa) channels in vascular smooth muscle cells (VSMC) in addition to endothelium-derived NO. GS induced vasorelaxation in rat aortic rings, which had been precontracted with phenylephrine, in a concentration-dependent manner. This GS-induced relaxation was partially reversed by tetraethylammonium (TEA), an inhibitor of KCa channels; methylene blue (MB), an inhibitor of soluble guanylate cyclase; as well as Nomega-nitro-L-arginine (L-NNA), but not by glybenclamide. In cultured VSMC and endothelial cells, KCa channels were activated by GS. This action was abolished by TEA, but was not blocked by glybenclamide. In addition, the GS-induced activity of KCa channels was partially inhibited by MB or H-8. These results indicate that the activation of KCa channels involved, at least in part, the GS-induced vasorelaxation of rat aorta.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11152372     DOI: 10.1097/00005344-200101000-00005

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  11 in total

1.  American ginseng supplementation attenuates creatine kinase level induced by submaximal exercise in human beings.

Authors:  Cheng-Chen Hsu; Min-Chen Ho; Li-Chin Lin; Borcherng Su; Mei-Chich Hsu
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

Review 2.  Therapeutic potential of ginseng in the management of cardiovascular disorders.

Authors:  Morris Karmazyn; Melissa Moey; Xiaohong Tracey Gan
Journal:  Drugs       Date:  2011-10-22       Impact factor: 9.546

Review 3.  Chemical components of ginseng, their biotransformation products and their potential as treatment of hypertension.

Authors:  Morris Karmazyn; Xiaohong Tracey Gan
Journal:  Mol Cell Biochem       Date:  2020-09-17       Impact factor: 3.396

Review 4.  Current evaluation of the millennium phytomedicine- ginseng (II): Collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese medicine.

Authors:  Lee Jia; Yuqing Zhao; Xing-Jie Liang
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 5.  Yin and Yang of ginseng pharmacology: ginsenosides vs gintonin.

Authors:  Dong-soon Im; Seung-yeol Nah
Journal:  Acta Pharmacol Sin       Date:  2013-10-14       Impact factor: 6.150

Review 6.  Ginseng ginsenoside pharmacology in the nervous system: involvement in the regulation of ion channels and receptors.

Authors:  Seung-Yeol Nah
Journal:  Front Physiol       Date:  2014-03-19       Impact factor: 4.566

7.  Efficacy of Ginseng Supplements on Fatigue and Physical Performance: a Meta-analysis.

Authors:  Hoang Viet Bach; Jeongseon Kim; Seung Kwon Myung; Young Ae Cho
Journal:  J Korean Med Sci       Date:  2016-12       Impact factor: 2.153

8.  Characterisation of the vasodilation effects of DHA and EPA, n-3 PUFAs (fish oils), in rat aorta and mesenteric resistance arteries.

Authors:  Roshan Limbu; Graeme S Cottrell; Alister J McNeish
Journal:  PLoS One       Date:  2018-02-02       Impact factor: 3.240

9.  Protein target identification of ginsenosides in skeletal muscle tissues: discovery of natural small-molecule activators of muscle-type creatine kinase.

Authors:  Feiyan Chen; Kexuan Zhu; Lin Chen; Liufeng Ouyang; Cuihua Chen; Ling Gu; Yucui Jiang; Zhongli Wang; Zixuan Lin; Qiang Zhang; Xiao Shao; Jianguo Dai; Yunan Zhao
Journal:  J Ginseng Res       Date:  2019-03-07       Impact factor: 6.060

10.  Ginsenoside Rb1 exerts antiarrhythmic effects by inhibiting INa and ICaL in rabbit ventricular myocytes.

Authors:  Zhipei Liu; Lv Song; Peipei Zhang; Zhenzhen Cao; Jie Hao; Youjia Tian; Antao Luo; Peihua Zhang; Jihua Ma
Journal:  Sci Rep       Date:  2019-12-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.